HOME >> BIOLOGY >> NEWS
Nuts cut coronary heart disease risk

University Park, Pa. --- In the most comprehensive review yet of the available epidemiological and clinical evidence, Penn State researchers have concluded that eating tree nuts or peanuts can have a strong protective effect against coronary heart disease. Dr. Penny Kris-Etherton, distinguished professor of nutrition and lead author of the review, says, "To date, five large epidemiologic studies and 11 clinical studies have demonstrated that frequent consumption of nuts decreases the risk of coronary heart disease."

The most improvement comes with adding very small amounts of nuts an ounce, or about three to four tablespoons, five or more times a week.

"However, you can't simply add nuts, nut butters or nut oils to your usual diet without making some adjustments," Kris-Etherton says. "You have to replace some of the calories you usually consume with nuts and substitute the unsaturated fat in nuts for some of the saturated fat in your diet."

The study was published today (May 8) in the current issue of the journal, Nutrition Reviews. Kris-Etherton's co-authors are Guixiang Zhao, a doctoral candidate and a Kligman Scholar in Nutrition; Amy E. Binkoski, doctoral candidate in Penn State's Life Sciences Consortium; Stacie M. Coval, master's degree candidate; and Dr. Terry Etherton, distinguished professor and head of the dairy and animal sciences department.

The researcher's review of the existing published epidemiologic studies shows that consuming 1 ounce of nuts more than 5 times/week can result in a 25 to 39 percent reduction in coronary heart disease risk among people whose characteristics match those of the general adult U.S. population.

Among the nuts consumed by the people who took part in the epidemiologic studies were almonds, brazil nuts, cashews, hazelnuts, macademia nuts, pecans, pistachios, and walnuts, as well as peanuts. However, the effects of specific nuts on coronary heart disease risk were not evaluated in these studies
'"/>

Contact: Barbara Hale
bah@psu.edu
814-865-9481
Penn State
7-May-2001


Page: 1 2 3

Related biology news :

1. Calcium channels control coronary artery relaxation
2. Calcium channel involved in coronary artery relaxation
3. Estrogen receptor-a disruption and vasodilation in coronary arteries
4. Higher blood levels of sitosterol may be associated with increased risk for coronary events
5. Protein mimetics could lead to more successful coronary bypasses
6. Combination drug therapy drastically reduces multiple coronary heart disease risk factors
7. Intracoronary gene therapy trial shows promise for treatment of angina
8. Two cholesterol-lowering statin drugs reduce another marker of coronary-artery disease
9. New research on safety of intracoronary delivery of adenovector reported in cover story of Molecular Therapy
10. Gene link to increased risk of coronary heart disease, found by scientists
11. Gene link to increased risk of coronary heart disease found by scientists

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ARMONK, N.Y. and ITHACA, N.Y. ... IBM ) and Cornell University, a leader in dairy ... combined with bioinformatics designed to help reduce the chances ... breaches. With the onset of this dairy project, Cornell ... the Consortium for Sequencing the Food Supply Chain, a ...
(Date:5/23/2017)... -- Hunova, the first robotic gym for the rehabilitation and functional motor sense ... Genoa, Italy . The first 30 robots will be available ... USA . The technology was developed and patented at the IIT ... Movendo Technology thanks to a 10 million euro investment from entrepreneur Sergio ... ...
(Date:5/16/2017)...   Bridge Patient Portal , an enterprise ... EMR Systems , an electronic medical record solutions ... established a partnership to build an interface between ... Centricity™ products, including Centricity Practice Solution (CPS), Centricity ... new integrations will allow healthcare delivery networks using ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... Palo Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... is set to take place on 7th and 8th June 2018 in San Francisco, ... and policy influencers as well as several distinguished CEOs, board directors and government officials ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... compared the implantation and pregnancy rates in frozen and fresh in vitro ... of progesterone and maternal age to IVF success. , After comparing the results ...
(Date:10/10/2017)... ... ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... event entitled “Stem Cells and Their Regenerative Powers,” was held on August 31st, ... was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic Surgery, ...
(Date:10/9/2017)...  BioTech Holdings announced today identification and patenting ... stem cell therapy prevents limb loss in animal ... that treatment with ProCell resulted in more than ... to standard bone marrow stem cell administration.  Interestingly, ... of therapeutic effect.  ...
Breaking Biology Technology:
Cached News: